See The BCR-ABLT315I mutation compromises survival in chronic phase chronic myelogenous leukemia patients resistant to tyrosine kinase inhibitors, in a matched pair analysis
http://www.haematologica.org/content/early/2013/05/03/haematol.2012.0802...